Table 2.
Patient characteristics at baseline
| Usual care (UC) N=133 | UC+website N=138 | UC+website+consultations N=148 | |
|---|---|---|---|
| Socio-demographic characteristics | |||
| Age, in yearsa | 60.4 (10.0) | 60.2 (8.8) | 60.9 (11.8) |
| Sex Femaleb | 36 (27.1) | 38 (27.5) | 49 (33.1) |
| Education levelb | |||
| Primary | 28 (21.9) | 20 (16.4) | 18 (14.4) |
| Secondary | 65 (50.8) | 65 (53.3) | 55 (44) |
| University | 35 (27.3) | 37 (30.3) | 52 (41.6) |
| Labourb | |||
| Paid labour | 45 (33.8) | 61 (44.2) | 47 (31.7) |
| Unemployed | 7 (5.2) | 4 (3) | 2 (1.3) |
| Unfit for work | 21 (16.0) | 24 (17.4) | 28 (19) |
| Retired | 50 (37.5) | 42 (30.4) | 63 (24.3) |
| Housewife | 10 (7.5) | 7 (5.0) | 8 (5.4) |
| Country of origin is the Netherlandsb | 110 (89.4) | 108 (91.5) | 109 (88.6) |
| Clinical Characteristics | |||
| Reason referralb | 51 (37.0) | 53 (36.0) | |
| Acute coronary syndrome | 46 (34.5) | 64 (46.4) | 69 (46.5) |
| Stroke or transient ischemic attack | 65 (49.0) | 23 (16.6) | 26 (17.5) |
| Peripheral arterial disease | 22 (16.5) | ||
| Blood pressure, mmHga | 135.5 (17.5) | 136.7 (19.7) | |
| Systolic | 137.3 (16.8) | 78.2 (9.6) | 76.5 (10.7) |
| Diastolic | 78.1 (11.3) | ||
| Lipids mmol/La | 4.5 (1.0) | 4.5 (1) | |
| Total cholesterol | 4.6 (1.2) | 1.7 (0.9) | 1.8 (1.1) |
| Triglyceriden | 1.9 (1.0) | 1.1 (0.3) | 1.2 (0.3) |
| High- density cholestrol | 1.2 (0.3) | 2.6 (0.9) | 2.5 (0.9) |
| Low-density lipoprotein | 2.6 (1.0) | 27.5 (4.0) | 27.1 (4) |
| Body mass index, kg/m2,a | 27.2 (4.0) | ||
| Medication useb | |||
| Medication (ATC) used | |||
| Antithrombotic agents (B01) | 128 (98.5) | 132 (97.1) | 144 (98.0) |
| Diuretics (C03) | 36 (26.5) | 36 (26.5) | 37 (25.1) |
| Beta blocking agents (C07) | 72 (55.4) | 85 (62.5) | 82 (55.8) |
| Calcium channel blockers (C08) | 20 (15.4) | 21 (15.4) | 24 (16.3) |
| Agents acting on the angiotensin system (C09) | 76 (58.5) | 83 (61.0) | 85 (57.8) |
| Lipid modifying agents (C10) | 120 (92.3) | 129 (95.0) | 138 (93.9) |
| Chronic users(b+c+d) | 85 (64.4) | 85 (62) | 90 (61.2) |
| Questionnaires | |||
| The Modified Morisky Scale (MMS) | |||
| Adherenceb | |||
| Low | 23 (18.9) | 21 (17.1) | 26 (20.5) |
| Medium | 63 (51.6) | 54 (43.9) | 53 (41.7) |
| High | 36 (29.5) | 48 (39) | 48 (37.8) |
| Beliefs about medication questionnaire | |||
| Necessity concern differentiala | 3.9 (4.9) | 3.9 (4.4) | 3.6 (4.6) |
| Categoriesb | |||
| Accepting | 35 (28.7) | 33 (26.6) | 32 (25) |
| Ambivalent | 81 (66.4) | 87 (70.2) | 87 (68) |
| Sceptical | 4 (3.3) | 2 (1.6) | 3 (2.3) |
| Indifferent | 2 (1.6) | 2 (1.6) | 6 (4.7) |
| Mean possesion ratiod,e | |||
| Cardiovascular medication total | 0.74 | 0.73 | 0.72 |
| Antithrombotic agents (B01) | 0.79 | 0.75 | 0.73 |
| Diuretics (C03) | 0.77 | 0.81 | 0.73 |
| Beta blocking agents (C07) | 0.86 | 0.87 | 0.83 |
| Calcium channel blockers (C08) | 0.96 | 0.95 | 0.94 |
| Agents acting on the angiotensin system (C09) | 0.80 | 0.80 | 0.79 |
| Lipid modifying agents (C10) | 0.82 | 0.79 | 0.76 |
Notes: aData are presented as mean (±SD). bData are presented as number (%). cChronic use =starting medication > 2 months before baseline. dData from imputated data. eMean number of days dispended divided by the mean number of days between prescription refill.